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As I assume the role of Editor-in-Chief of Current Therapeutic Research, I hope 
to continue the journal's objective of providing exceptional and informative 
publications to the scientific ommunity. Under the leadership of Dr. Michael 
Weintraub, Current Therapeutic Research as focused on providing high-quality 
articles to a global audience in a timely fashion. The bimonthly journal is 
now distributed to over 33 countries and has an online readership exceeding 
6 million. During his tenure, Dr. Weintraub also established the Trials in Special 
Populations section in an effort o recognize the importance of therapeutic trials 
that address the diversity in our changing world. I am pleased that Dr. Weintraub 
will continue to serve the journal as Editor Emeritus. I look forward to build- 
ing on the journal's progress as I assume the role of Editor-in-Chief. 
I bring to the journal a background in both medicine and public health. 
I completed training in internal medicine and pediatrics at Duke University 
before focusing on infectious diseases training at the University of Washington. 
I am committed to research in resource-poor settings, primarily focusing on 
HIV/AIDS and parasitic diseases. My research as led me all over the globe, 
from Nepal and Thailand to my current area of interest, Kenya. I believe this 
background will strongly influence my goals as Editor-in-Chief of Current 
Therapeutic Research. 
My hope for the continued excellence of the journal began with a simple 
question: what can Current Therapeutic Research offer the global scientific 
community that the thousands of other available scientific journals do not? 
In reading issues from the past few years, I found several aspects of Current 
Therapeutic Research that I think are both unique and important. The most 
significant of these is the commitment of the editorial board to the timely 
publication of high-quality scientific data from all areas of the world. 
New information must be made available rapidly to keep pace with the 
increasing speed of scientific development and acquisition of knowledge. 
The strong commitment of Current Therapeutic Research to review and pub- 
lish articles quickly means that new advances in therapeutic research can be 
available in print within weeks of acceptance. 
Another unique attribute of Current Therapeutic Research is our commit- 
ment to working with authors for whom English may not be a native language. 
Current Therapeutic Research employs a talented editorial staff who can assist 
authors in producing articles in clear, concise language, ensuring that their 
scientific data are easily understood by the journal's international readership. 
While the future may seem unpredictable in many regards, some direc- 
tions of change are quite evident. We are becoming an increasingly interde- 
pendent global community. International events have a direct and immediate 
impact on our lives like never before. In addition, information is being dis- 
seminated to a much wider audience and at an incredible pace. It is my hope 
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that by continuing to focus on publishing scientific data of exceptional quality 
from around the world, and by doing so in an efficient and timely manner, 
Current Therapeutic Research will continue to fill a unique and important 
niche in the world of scientific publishing. 
Judd L. Walson, MD, MPH 
Editor-in-Ch ief 
